The Children's Hospital-University of Birmingham
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Reeves, Ginger
NCT05199285: A Phase II Study of Nivolumab + Ipilimumab in Advanced HCC Patients Who Have Progressed on First Line Atezolizumab + Bevacizumab

Recruiting
2
40
US
Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS-734016, Ipilimumab Biosimilar CS1002, MDX-010, MDX-CTLA4, Yervoy, Nivolumab, BMS-936558, CMAB819, MDX-1106, NIVO, Nivolumab Biosimilar CMAB819, ONO-4538, Opdivo
Academic and Community Cancer Research United, National Cancer Institute (NCI)
BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8, Stage IVA Hepatocellular Carcinoma AJCC v8, Stage IVB Hepatocellular Carcinoma AJCC v8, Unresectable Hepatocellular Carcinoma
01/24
01/27
NCT05194293: Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer

Recruiting
2
30
US
Durvalumab, Imfinzi, Immunoglobulin G1, Anti-(Human Protein B7-H1) (Human Monoclonal MEDI4736 Heavy Chain), Disulfide with Human Monoclonal MEDI4736 Kappa-chain, Dimer, MEDI-4736, MEDI4736, Regorafenib, BAY 73-4506, Regorafenib Anhydrous
Academic and Community Cancer Research United, National Cancer Institute (NCI)
Stage IB Hepatocellular Carcinoma AJCC v8, Stage II Hepatocellular Carcinoma AJCC v8, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8
12/24
12/28
SOLARA, NCT04711824: Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Recruiting
1/2
41
US
Olaparib, Lynparza, Stereotactic Radiosurgery, SRS, Durvalumab, Imfinzi, Physicians Choice systemic chemotherapy, Paclitaxel, Nab-paclitaxel, Eribulin, Carboplatin, Cisplatin, Capecitabine, Gemcitabine
Colette Shen, AstraZeneca, University of North Carolina, Chapel Hill
Breast Cancer, Brain Metastases, Adult
11/25
11/26
ICC, NCT04989218: Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma

Terminated
1/2
1
US
Novel combination of chemotherapy and immunotherapy, Cisplatin (Platinol), Gemcitabine (Gemzar), Durvalumab (Imfimzi), Tremelimumab
University of Alabama at Birmingham
Cholangiocarcinoma
03/24
05/24
NCT03587961: Personalized Theratyping Trial

Recruiting
1
20
US
Symdeko, Orkambi, Ivacaftor
University of Alabama at Birmingham
Cystic Fibrosis
01/26
09/26
NCT03256773: High Resolution Micro OCT Imaging

Recruiting
N/A
60
US
University of Alabama at Birmingham, Massachusetts General Hospital
Cystic Fibrosis, COPD, PCD - Primary Ciliary Dyskinesia, Covid19, Sinusitis
12/24
12/24

Download Options